Skip to main content
. 2023 Mar 20;9(2):00423-2022. doi: 10.1183/23120541.00423-2022

FIGURE 1.

FIGURE 1

Consolidated Standards of Reporting Trials flow diagram of study population demonstrating the number of eligible participants, those initiated on nintedanib, those reaching primary analysis criteria of sequential lung function and adherence to the compassionate access programme.